Fair call regarding a deal with Beta Cell Technologies but after watching the very interesting webinar....it seems they are both very open to striking something that would work for both companies. I guess I am just thinking (probably shouldn't assume) that they have spent 10 years together perfecting BTM for the task so its a fait acompli...that they will sign a deal. The next big challenge is getting enough Pancreatic islets to service the millions of people around the world with T1D. They cant rely on harvesting from dead people to meet too many patients. Vectus seem the best placed...if they are interested.
PNV Price at posting:
$1.49 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)